Free

"Health Economics: it’s not (only) about the costs, it’s about the added va...

Event Information

Share this event

Date and Time

Location

Location

Clark Kennedy Lecture Theatre

Queen Mary Innovation Building

5 Walden Street, Whitechapel

London

E1 2EF

United Kingdom

View Map

Event description

Description

“Health Economics: it’s not (only) about the costs, it’s about the added value” by Professor Borislava Mihaylova

Part of SMD Inaugural Lecture Series


In this lecture, Professor Borislava Mihaylova will provide an overview of her work on effects of chronic conditions on long-term survival, quality of life and costs and the net effects of interventions to reduce disease risks in people with such conditions. Examples from the cardiovascular and kidney diseases and obesity will illustrate a growing agenda towards informing decisions for individual patients.

Abstract

The increasing burden of chronic conditions, growing healthcare needs, and evolving range of existing and new interventions has placed health economics in the forefront of healthcare decision making. Its increasingly complex frameworks synthesize the evidence on benefits, harms, resources and costs of diseases and interventions to inform decisions for efficient use of resources to achieve best health outcomes. In her inaugural lecture, Professor Mihaylova will discuss her work on effectiveness and cost-effectiveness of lipid modifying interventions to reduce cardiovascular disease risks in different populations and her research agenda towards developing evaluative frameworks to assess long-term net effects of interventions in categories of patients and ultimately in individual patients. The growing availability of data and evolving methods are rapidly increasing the possibilities for such approaches informing doctor-patient discussions and treatment decisions.

Brief Biography

Borislava Mihaylova is a Professor of Health Economics at the Centre for Primary Care and Public Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London and leads the work of the health economics team at the Centre.

She trained in Computer Sciences and Finance (Sofia, Bulgaria), Health Economics (York, UK) and Public Health/Health Economics (Oxford, UK). Borislava’s research interests are in the field of health economic evaluation and health policy analyses with particular focus on cost-effectiveness analysis alongside clinical trials, evidence synthesis, heterogeneity in cost-effectiveness, and statistical and epidemiologic methods in these areas. She is involved in studies of effectiveness and cost-effectiveness of cardiovascular interventions in a number of large clinical trials at the University of Oxford (HPS, SHARP, THRIVE, REVEAL, ASCEND, ACST-2) and in studies of a wider range of interventions at QMUL (CHILL, OPTIMISE, FLO-ELA, ASSURED, IBD-BOOST). Her work on effectiveness and cost-effectiveness of statins for cardiovascular disease prevention has been particularly influential in informing treatment recommendations for people at different vascular disease risk.

Share with friends

Date and Time

Location

Clark Kennedy Lecture Theatre

Queen Mary Innovation Building

5 Walden Street, Whitechapel

London

E1 2EF

United Kingdom

View Map

Save This Event

Event Saved